Posted on

2023 Week 22: AbbVie Inc (NYSE: ABBV)

ABBV

Portfolio Update

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend (Q2 2023)$817.47
LifeTime Dividend$10,991.05
Estimated Annual Dividend$9,348.14
Dividend Scorecard

The capital allocation for the week of 05/28/2023 to 06/03/2023 will be used to add to our position in AbbVie Inc (NYSE: ABBV)

ABBV – Position Update

Since our last check-in on ABBV in week 21 of 2023, there have been no new developments. In addition, the share price declined 5% from $145.11 to $137.56.

Continue reading “2023 Week 22: AbbVie Inc (NYSE: ABBV)”
Posted on

2023 Week 21: AbbVie Inc (NYSE: ABBV)

ABBV

Portfolio Update

The FiveTwenty portfolio received $178.61 in dividends in the past week. ABBV, CAT, and PG paid their quarterly dividends during the week.

Past Week Dividend$178.61
Current Quarter Dividend (Q2 2023)$817.47
LifeTime Dividend$10,991.05
Estimated Annual Dividend$9,268.65
Dividend Scorecard

The capital allocation for the week of 05/21/2023 to 05/27/2023 will be used to add to our position in AbbVie Inc (NYSE: ABBV)

ABBV – Position Update

Since our last check-in on ABBV in week 51 of 2021, the company reported FY 2021 earnings on 02/02/2022, FY 2022 earnings on 02/09/2023, and Q1 2023 earnings on 04/27/2023. In addition, the share price increased 12% from $129.53 to $145.11.

Continue reading “2023 Week 21: AbbVie Inc (NYSE: ABBV)”
Posted on

2021 Week 51: AbbVie Inc (NYSE: ABBV)

ABBV

Portfolio Update

The FiveTwenty portfolio received $145.90 in dividends in the past week. K, MMM, and ORI paid their quarterly dividend during the week.

Past Week Dividend$119.40
Current Quarter Dividend (Q4 2021)$928.02
LifeTime Dividend$2,029.35
Estimated Annual Dividend$3,778.45
Dividend Scorecard

The capital allocation for the week of 12/19/2021 to 12/25/2021 will be used to add to our position in AbbVie Inc (NYSE: ABBV)

ABBV – Position Update

Since our last check-in on ABBV in week 11 of 2021, the company reported Q1 2021 earnings on 04/30/2021, Q2 2021 earnings on 07/30/2021, and Q3 2021 earnings on 10/29/2021. Additionally, the share price increased 19.7% from $108.22 to $129.53 during the same period.

Continue reading “2021 Week 51: AbbVie Inc (NYSE: ABBV)”
Posted on

2021 Week 11: AbbVie Inc (NYSE: ABBV)

ABBV

Portfolio Update

The FiveTwenty portfolio received $18.70 in the past week. WBA paid it’s quarterly dividend during the week.

Past Week Dividend$18.70
Current Quarter Dividend$84.57
Estimated Annual Dividend$741.17
LifeTime Dividend$84.57
Dividend Scorecard

The capital allocation for the week of 03/14/2021 to 03/20/2021 will be used to add to our position in AbbVie Inc (NYSE: ABBV)

ABBV – Update

Since out last check-in on ABBV in week 4 of 2021, the company reported Q4 and full year 2020 earnings on 02/03/2021. Additionally the share price has been more or less flat closing at $108.22 on 03/12/2021 compared to a close of $110.86 on 01/22/2021, 2.3% decline.

Continue reading “2021 Week 11: AbbVie Inc (NYSE: ABBV)”
Posted on

What is a contingent consideration liability?

contingent consideration

In it’s Q4 2020 earnings release AbbVie (NYSE: ABBV) reported that it recorded a $4.7 billion increase in the contingent consideration liability for the drug Skyrizi. This expense wiped out ABBV’s net earnings for the quarter. Therefore, I decided to do some research to try to understand what a contingent consideration liability is.

What is a contingent consideration?

Contingent considerations are financial instruments employed in complex business transactions. Their purpose is to share risk associated with the transaction between buyers and sellers. A contingent consideration is an obligation of the buyer to transfer additional assets (cash, equity, physical assets) to the seller if future events occur or conditions are met.

Continue reading “What is a contingent consideration liability?”
Posted on

2021 Week 4: AbbVie Inc (NYSE: ABBV)

ABBV

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend$0
LifeTime Dividend$0
Dividend Scorecard

The capital allocation for the week of 01/24/2021 to 01/30/2021 will be used to establish a position in AbbVie Inc (NYSE: ABBV).

ABBV – Company Profile

AbbVie (ABBV) is a biopharmaceutical company founded in 2013 as a spin-off of Abbot Laboratories. The company develops and sells treatments in the areas of: immunology, hematologic oncology, aesthetics, neuroscience, eye care, women’s health and others. It’s best known products are Humira and Botox. Official Site | Wikipedia

Continue reading “2021 Week 4: AbbVie Inc (NYSE: ABBV)”